A. Löffler

发表

Pharmacochaperones Post-translationally Enhance Cell Surface Expression by Increasing Conformational Stability of Wild-type and Mutant Vasopressin V2 Receptors*

B. Wiesner, G. Krause, M. Schaefer, 2004, Journal of Biological Chemistry.

A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

B. Dörken, P. Kufer, G. Riethmüller, 2000, Blood.

Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6

M. Blaut, G. Henderson, U. Karsten, 2013, Cancer Immunology, Immunotherapy.

CTL-Assays for Functional Testing of Bispecific Antibody Fragments

R. Bargou, T. Dreier, A. Löffler, 2001 .

Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.

S. Nishimura, A. Flechner, R. Dölling, 2019, International immunopharmacology.

Occurrence of the human tumor-specific antigen structure Galβ1-3GalNAcα- (Thomsen-Friedenreich) and related structures on gut bacteria: prevalence, immunochemical analysis and structural confirmation.

W. Reutter, M. Blaut, G. Henderson, 2011, Glycobiology.

PankoMab: a potent new generation anti-tumour MUC1 antibody

R. Stahn, A. Märten, U. Karsten, 2006, Cancer Immunology, Immunotherapy.

Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

B. Dörken, P. Kufer, C. Wuchter, 2003, Leukemia.